Dr Abdullah Isreb

Journal article

Isreb A, Alhnan MA, Mkia A, Al-Jammal K, Yaghi AM, Oga EF, Timmins P, Bonner M, Forbes RT. 2025. Evaluation of Drug-Polymer and Drug-Drug Interaction in Cellulosic Multi-Drug Delivery Matrices Methods and protocols, 8 :4 DOI Author Url Publisher Url Public Url

Liu Y, Leonova AM, Royall PG, Abdillah Akbar BVEB, Cao Z, Jones SA, Isreb A, Hawcutt DB, Alhnan MA. 2023. Laser-cutting: A novel alternative approach for point-of-care manufacturing of bespoke tablets International Journal of Pharmaceutics, 647 DOI Author Url Publisher Url Public Url

Yang TL, Stogiannari M, Janeczko S, Khoshan M, Lin Y, Isreb A, Habashy R, Giebułtowicz J, Peak M, Alhnan MA. 2023. Towards point-of-care manufacturing and analysis of immediate-release 3D printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia International Journal of Pharmaceutics, 642 DOI Author Url Publisher Url

Yang TL, Szewc J, Zhong L, Leonova A, Giebułtowicz J, Habashy R, Isreb A, Alhnan MA. 2023. The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care International Journal of Pharmaceutics, 642 :123073 DOI Author Url Publisher Url Public Url

Bracken L, Habashy R, McDonough E, Wilson F, Shakeshaft J, Ohia U, Garcia-Sorribes T, Isreb A, Alhnan MA, Peak M. 2022. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People Pharmaceutics, 14 :516-516 DOI Author Url Publisher Url Public Url

Habashy R, Khoder M, Isreb A, Alhnan MA. 2022. A Novel Multilayer Natural Coating for Fed-State Gastric Protection Pharmaceutics, 14 DOI Author Url Publisher Url Public Url

Yousaf SS, Isreb A, Khan I, Mewsiga E, Elhissi A, Ahmed W, Alhnan MA. 2021. Impact of Nanosizing on the Formation and Characteristics of Polymethacrylate Films: Micro- versus Nano- suspensions. Pharmaceutical Development and Technology, 26 :729-739 DOI Author Url Publisher Url Public Url

Okwuosa TC, Sadia M, Isreb A, Habashy R, Peak M, Alhnan MA. 2021. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment International Journal of Pharmaceutics, 600 :120442 DOI Author Url Publisher Url Public Url

Kuźmińska M, Pereira BC, Habashy R, Peak M, Isreb M, Gough TD, Isreb A, Alhnan MA. 2021. Solvent-free temperature-facilitated direct extrusion 3D printing for pharmaceuticals International Journal of Pharmaceutics, 598 :120305 DOI Author Url Publisher Url Public Url

Pereira BC, Isreb A, Isreb M, Forbes RT, Oga EF, Alhnan MA. 2020. Computer‐aided Drug Design: Additive Manufacturing of a Point‐of‐Care “Polypill:” Fabrication of Concept Capsules of Complex Geometry with Bespoke Release against Cardiovascular Disease (Adv. Healthcare Mater. 13/2020) Advanced Healthcare Materials, 9 DOI Publisher Url

Pereira BC, Isreb A, Isreb M, Forbes RT, Oga EF, Alhnan MA. 2020. Additive Manufacturing of a Point-of-Care “Polypill:” Fabrication of Concept Capsules of Complex Geometry with Bespoke Release against Cardiovascular Disease Advanced Healthcare Materials, 9 :e2000236 DOI Author Url Publisher Url

Khan I, Lau K, Bnyan R, Houacine C, Roberts M, Isreb A, Elhissi A, Yousaf S. 2020. A Facile and Novel Approach to Manufacture Paclitaxel-Loaded Proliposome Tablet Formulations of Micro or Nano Vesicles for Nebulization. Pharmaceutical Research, 37 DOI Author Url Publisher Url Public Url

Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb A, Peak M, Alhnan MA. 2019. Embedded 3D printing of novel bespoke soft dosage form concept for pediatrics Pharmaceutics, 11 :630-630 DOI Author Url Publisher Url Public Url

Peak M, Baj K, Isreb A, Wojsz M, Mohammad I, Albed Alhnan M. 2019. O22 3D printed polyethylene oxide oral doses with innovative ‘radiator-like’ design: impact of molecular weight on mechanical and rheological properties and drug release Archives of Disease in Childhood, 104 :e10.1-e10 DOI Publisher Url

Okwuosa TC, Pereira BC, Arafat B, Cieszynska M, Isreb A, Alhnan MA. 2016. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy Pharmaceutical Research, 34 :427-437 DOI Author Url Publisher Url

Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA. 2016. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets Pharmaceutical Research, 33 :2704-2712 DOI Author Url Publisher Url

Pietrzak K, Isreb A, Alhnan MA. 2015. A flexible-dose dispenser for immediate and extended release 3D printed tablets European Journal of Pharmaceutics and Biopharmaceutics, 96 :380-387 DOI Author Url Publisher Url Public Url

Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan MA. 3D printed oral theophylline doses with innovative ‘radiator-like’ design: Impact of polyethylene oxide (PEO) molecular weight International Journal of Pharmaceutics, 564 :98-105 DOI Author Url Publisher Url

Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, Alhnan MA, Oga EF. ‘Temporary Plasticiser’: A novel solution to fabricate 3D printed patient-centred cardiovascular ‘Polypill’ architectures European Journal of Pharmaceutics and Biopharmaceutics, 135 :94-103 DOI Author Url Publisher Url

Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, Timmins P, Alhnan MA. From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets European Journal of Pharmaceutical Sciences, 123 :484-494 DOI Author Url Publisher Url

Arafat B, Wojsz M, Isreb A, Forbes RT, Isreb M, Ahmed W, Arafat T, Alhnan MA. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets European Journal of Pharmaceutical Sciences, 118 :191-199 DOI Author Url Publisher Url

Sadia M, Sośnicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, Alhnan MA. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets International Journal of Pharmaceutics, 513 :659-668 DOI Author Url Publisher Url

Habashy R, Khoder M, Zhang S, Pereira B, Bohus M, Tzu-Wen Wang J, Isreb A, Alhnan MA. An innovative wax-based enteric coating for pharmaceutical and nutraceutical oral products International Journal of Pharmaceutics, 591 :119935 DOI Author Url Publisher Url

Dores F, Kuźmińska M, Soares C, Bohus M, A Shervington L, Habashy R, Pereira BC, Peak M, Isreb A, Alhnan MA. Temperature and solvent facilitated extrusion based 3D printing for pharmaceuticals European Journal of Pharmaceutical Sciences, 152 :105430 DOI Author Url Publisher Url

External PGR examinations performed:

University of Bradford, PhD, DEVELOPMENT OF NOVEL DEEP EUTECTIC SOLVENTS FOR OPTIMIZATION AND CHARACTERIZATION, INVOLVING BIO EXTRACTION AND DELIVERY VEHICLE OF DRUGS WITH POOR SOLUBILITY. 2023

University of Bradford, PhD, Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid. 2022

University of Central Lancashire, MPhil, Investigating the Role of Periodontal Disease on Inducing Alzheimer’s Disease-like Phenotype. 2022

External collaboration:

University of Huddersfield, Prof Peter Timmins. 2023

University of Sheffield, Dr Abdallah Yaghi collaborating on a research topic. 2023

Royal Liverpool University Hospital, Dr Emily Hoodless, Dr Dennis Wat, Dr Dilip Nazareth. 2023

University of Central Lancashire, Dr Asa Auta, Mrs Bina Kadri. 2022

University of Central Lancashire, Dr Enoche Oga. 2022

Kings College University, Dr Mohamed Alhnan. 2018

University of Bradford, Dr Mohammed Isreb. 2015

PPM Nogra, University of Liverpool, University of Central Lancashire and Prof Peter Timmins as independant researcher, as above, the collaboration is still ongoing, we are still in signing the CDA form with the company, since it was between so many institution it was really hard to arrange.

Quay Pharma, Quay Pharma now known as SGS, we are trying to set up a PhD project and collaboration, still early stage, discussion has been initiatied and waiting for the unniversity agreement in addition to Quay agreement.

Public engagement:

Other, NHS staff and patients, Rider, Member, BloodBike, Member of Bloodbike charity that assist the NHS in transporting vital materials, tests, equipments and other important items between Merseside and Cheshire trusts. 2022

Editorial boards:

Advanced formulation - 3D printing, Guest editor. 2021

Research Grants Awarded:

School of Pharmacy and Biomedical Sciences - University of Central Lancashire, Novel approach to transform the immunogenecity of red blood cells - toward creation of a universal red blood cell, Dr Vikesh Chhabria, Dr Laura McShane, Grant value (£): £5000, Duration of research project: 1 year. 2015

Other Professional Activity:

Syrian British Medical Society, exchange medical information and research. 2014

Teaching qualification:

Teaching Tool kit. 2014

Conference presentation:

academy of pharmaceutical Science, APS International Pharmaceutical Sciences, Nottingham, Poster presentation. 2011

American Association of Pharmaceutical Scientists, Conference of Pharmaceutical Scientist, New Orleans, Poster presentation. 2010

Fellowships:

Fellow, Higher Education Academy.